Pfizer (PFE) Payout Ratio (2009 - 2026)

Pfizer (PFE) has reported Payout Ratio for 18 consecutive years, with 10.3 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payout Ratio fell 1333.27% year-over-year to 10.3 in Q2 2026; TTM through Jun 2026 was 2.24, a 111.38% increase from a year earlier, with the FY2025 full-year figure at 1.25, up 6.02% from the prior year.
• Payout Ratio was 10.3 for Q2 2026 at Pfizer, down from 0.91 in the prior quarter.
• Over five years, Payout Ratio peaked at 49.58 in Q2 2024 and troughed at 10.3 in Q2 2026.
• A 5-year average of 3.14 and a median of 0.72 in 2024 frame the typical range for Payout Ratio.
• Across the five-year window, Payout Ratio jumped 4907.6% in 2024 and slumped 1333.27% in 2026, its largest moves.
• Over 5 years, Payout Ratio stood at 0.23 in 2022, then tumbled by 404.3% to 0.69 in 2023, then jumped by 235.63% to 0.93 in 2024, then tumbled by 259.54% to 1.49 in 2025, then slumped by 590.77% to 10.3 in 2026.
• The last three Payout Ratio figures came in at 10.3 (Q2 2026), 0.91 (Q1 2026), and 1.49 (Q4 2025), per Business Quant data.